Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirus-infected cell

Biotechnology and Bioengineering

Volumn 104, Issue 6, 2009, Pages 1142-1152

  Hsu, Yueh Ying ^a   Liu, Yu Ning ^a,c   Lu, Wen Wen ^b   Kung, Szu Hao ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c Prevision Medical Corp   (Taiwan)

Author keywords

eIF4G; Enterovirus; Fluorescence resonance energy transfer (FRET); Protease 2A (2Apro); Translation

Indexed keywords

EIF4G; ENTEROVIRUS; FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET); PROTEASE 2A (2APRO); TRANSLATION;

BIOSENSORS; CELL MEMBRANES; ENERGY TRANSFER; RESONANCE; SIGNAL TRANSDUCTION;

FLUORESCENCE;

CASPASE; GREEN FLUORESCENT PROTEIN; INITIATION FACTOR 4G; PROTEINASE; RED FLUORESCENT PROTEIN;

ARTICLE; BIOSENSOR; CATALYSIS; CONTROLLED STUDY; ENTEROVIRUS; ENTEROVIRUS INFECTION; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; KINETICS; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VIRUS CELL INTERACTION;

ENTEROVIRUS; EUKARYOTIC INITIATION FACTOR-4G; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; PEPTIDE HYDROLASES; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS;

ENTEROVIRUS; EUKARYOTA;

EID: 70350516039     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22495     Document Type: Article

References (51)

1. Alvarez E, Menendez-Arias L, Carrasco L. 2003. The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J Virol 77(23):12392-12400. (Pubitemid 37430636)
2. Barco A, Feduchi E, Carrasco L. 2000. A stable HeLa cell line that inducibly expresses poliovirus 2Apro: Effects on cellular and viral gene expression. J Virol 74(5):2383-2392. (Pubitemid 30091493)
3. Bazan JF, Fletterick RJ. 1988. Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: Structural and functional implications. Proc Natl Acad Sci USA 85(21):7872-7876.
4. Bedard KM, Semler BL. 2004. Regulation of picornavirus gene expression. Microbes Infect 6(7):702-713.
5. Borman AM, Kirchweger R, Ziegler E, Rhoads RE, Skern T, Kean KM. 1997. elF4G and its proteolytic cleavage products: Effect on initiation of protein synthesis from capped, uncapped, and IRES-containing mRNAs. RNA 3(2):186-196. (Pubitemid 27074572)
6. Bovee ML, Lamphear BJ, Rhoads RE, Lloyd RE. 1998. Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro. Virology 245(2):241-249.
7. Buenz EJ, Howe CL. 2006. Picornaviruses and cell death. Trends Microbiol 14(1):28-36.
8. Calandria C, Irurzun A, Barco A, Carrasco L. 2004. Individual expression of poliovirus 2Apro and 3Cpro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Res 104(1):39-49. (Pubitemid 38724166)
9. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, Tsien RY. 2002. A monomeric red fluorescent protein. Proc Natl Acad Sci USA 99(12):7877-7882.
10. Clemens MJ, Bushell M, Morley SJ. 1998. Degradation of eukaryotic polypeptide chain initiation factor (eIF)4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17(22):2921-2931. (Pubitemid 29010062)
11. de Breyne S, Bonderoff JM, Chumakov KM, Lloyd RE, Hellen CU. 2008. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology 378(1):118-122.
12. Deszcz L, Seipelt J, Vassilieva E, Roetzer A, Kuechler E. 2004. Antiviral activity of caspase inhibitors: Effect on picornaviral 2A proteinase. FEBS Lett 560(1-3):51-55. (Pubitemid 38264292)
13. Deszcz L, Gaudernak E, Kuechler E, Seipelt J. 2005. Apoptotic events induced by human rhinovirus infection. J Gen Virol 86(5):1379-1389. (Pubitemid 40613256)
14. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. 1982. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257(24):14806-14810. (Pubitemid 13159573)
15. Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y, Luria S, Sonenberg N, Kahana C. 2000. Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol 20(4):1271-1277. (Pubitemid 30069248)
16. Gradi A, Imataka H, Svitkin YV, Rom E, Raught B, Morino S, Sonenberg N. 1998a. A novel functional human eukaryotic translation initiation factor 4G. Mol Cell Biol 18(1):334-342. (Pubitemid 28021044)
17. Gradi A, Svitkin YV, Imataka H, Sonenberg N. 1998b. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci USA 95(19):11089-11094. (Pubitemid 28450086)
18. Gradi A, Svitkin YV, Sommergruber W, Imataka H, Morino S, Skern T, Sonenberg N. 2003. Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF)4GI and eIF4GII are different. J Virol 77(8):5026-5029. (Pubitemid 36402855)
19. Haghighat A, Svitkin Y, Novoa I, Kuechler E, Skern T, Sonenberg N. 1996. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J Virol 70(12):8444-8450. (Pubitemid 26378421)
20. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77(1):51-59. (Pubitemid 19125653)
21. Hsu YY, Liu YN, Wang W, Kao FJ, Kung SH. 2007. In vivo dynamics of enterovirus protease revealed by fluorescence resonance emission transfer (FRET) based on a novel FRET pair. Biochem Biophys Res Commun 353(4):939-945.
22. Hubbard SJ. 1998. The structural aspects of limited proteolysis of native proteins. Biochim Biophys Acta 1382(2):191-206.
23. Jares-Erijman EA, Jovin TM. 2003. FRET imaging. Nat Biotechnol 21(11):1387-1395.
24. Kohl T, Heinze KG, Kuhlemann R, Koltermann A, Schwille P. 2002. A protease assay for two-photon crosscorrelation and FRET analysis based solely on fluorescent proteins. Proc Natl Acad Sci USA 99(19):12161-12166.
25. Krausslich HG, Nicklin MJ, Toyoda H, Etchison D, Wimmer E. 1987. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol 61(9):2711-2718. (Pubitemid 17143430)
26. Kuo R-L, Kung S-H, Hsu Y-Y, Liu W-T. 2002. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol 83(6):1367-1376.
27. Kuyumcu-Martinez NM, Joachims M, Lloyd RE. 2002. Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease. J Virol 76(5):2062-2074. (Pubitemid 34150674)
28. Lamphear BJ, Yan R, Yang F, Waters D, Liebig HD, Klump H, Kuechler E, Skern T, Rhoads RE. 1993. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J Biol Chem 268(26):19200-19203. (Pubitemid 23270688)
29. Lloyd RE. 2006. Translational control by viral proteinases. Virus Res 119(1):76-88.
30. Marissen WE, Lloyd RE. 1998. Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol Cell Biol 18(12):7565-7574.
31. Martinez-Abarca F, Alonso MA, Carrasco L. 1993. High level expression in Escherichia coli cells and purification of poliovirus protein 2Apro. J Gen Virol 74(12):2645-2652. (Pubitemid 24020657)
32. Molla A, Hellen CU, Wimmer E. 1993. Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J Virol 67(8):4688-4695. (Pubitemid 23215948)
33. Morley SJ, Coldwell MJ, Clemens MJ. 2005. Initiation factor modifications in the preapoptotic phase. Cell Death Differ 12(6):571-584.
34. Ohlmann T, Rau M, Pain VM, Morley SJ. 1996. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF)4G is sufficient to support cap-independent translation in the absence of eIF4E. EMBO J 15(6):1371-1382. (Pubitemid 26093473)
35. Ohlmann T, Prevot D, Decimo D, Roux F, Garin J, Morley SJ, Darlix JL. 2002. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J Mol Biol 318(1):9-20.
36. Palacios G, Oberste MS. 2005. Enteroviruses as agents of emerging infectious diseases. J Neurovirol 11(5):424-433. (Pubitemid 43064681)
37. Pallansch M, Roos R. 2007. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, editors. Fields Virology, 5th ed. Philadelphia: Lippincott Williams & Wilkins. pp 839-893.
38. Perales C, Carrasco L, Ventoso I. 2003. Cleavage of eIF4G by HIV-1 protease: Effects on translation. FEBS Lett 533(1-3):89-94. (Pubitemid 36206387)
39. Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsky IN, Agol VI, Hellen CU. 2001. Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci USA 98(13):7029-7036. (Pubitemid 32567898)
40. Roberts LO, Boxall AJ, Lewis LJ, Belsham GJ, Kass GE. 2000. Caspases are not involved in the cleavage of translation initiation factor eIF4GI during picornavirus infection. J Gen Virol 81(7):1703-1707.
41. Seipelt J, Liebig HD, Sommergruber W, Gerner C, Kuechler E. 2000. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J Biol Chem 275(26):20084-20089. (Pubitemid 30441618)
42. Söling A, Simm A, Rainov N. 2002. Intracellular localization of herpes simplex virus type 1 thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag. FEBS Lett 527(1-3):153-158. (Pubitemid 35253857)
43. Sommergruber W, Ahorn H, Klump H, Seipelt J, Zoephel A, Fessl F, Krystek E, Blaas D, Kuechler E, Liebig HD, Skern T. 1994. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology 198(2):741-745. (Pubitemid 124019514)
44. Starkuviene V, Pepperkok R. 2007. The potential of high-content high-throughput microscopy in drug discovery. Br J Pharmacol 152(1):62-71. (Pubitemid 47339900)
45. Svitkin YV, Gradi A, Imataka H, Morino S, Sonenberg N. 1999. Eukaryotic initiation factor 4GII (eIF4GII), but not eIF4GI, cleavage correlates with inhibition of host cell protein synthesis after human rhinovirus infection. J Virol 73(4):3467-3472. (Pubitemid 29135743)
46. Tawa P, Tam J, Cassady R, Nicholson DW, Xanthoudakis S. 2001. Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis. Cell Death Differ 8(1):30-37. (Pubitemid 32162218)
47. Tsai MT, Cheng YH, Liu YN, Liao NC, Lu WW, Kung SH. 2009. Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer. Antimicrob Agents Chemother 53(2):748-755.
48. Vaisberg EA, Lenzi D, Hansen RL, Keon BH, Finer JT. 2006. An infrastructure for high-throughput microscopy: Instrumentation, informatics, and integration. Methods Enzymol 414:484-512. (Pubitemid 44716238)
49. Ventoso I, Blanco R, Perales C, Carrasco L. 2001. HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc Natl Acad Sci USA 98(23):12966-12971. (Pubitemid 33051302)
50. Yang J, Zhang Z, Lin J, Lu J, Liu BF, Zeng S, Luo Q. 2007. Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor. Biochim Biophys Acta 1773(3):400-407. (Pubitemid 46275066)
51. Yu SF, Lloyd RE. 1991. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease. Virology 182(2):615-625.